Immunolab GmbH
Immuno diagnostics and analytical reagents for human health and food safety, developed and produced under ISO 9001 and ISO 13485 standards.
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 13 % | 2 % | (17 %) | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Immunolab specializes in the manufacturing of highly sensitive and specific immuno diagnostics and analytical reagents. The company's core business revolves around the in-house development and production of test kits, focusing on human health and the safety of nutrition.
Operating within the broader Eurofins group as a member of Eurofins Technologies, the firm leverages the agility of a mid-sized entity with the resources of a global network. Its business model is centered on producing and selling these diagnostic tools. The primary clientele appears to be laboratories and health practitioners, as indicated by their participation in proficiency testing and external quality assessment programs to validate laboratory methods according to ISO/IEC 17025 standards.
All manufacturing processes are certified under ISO 9001 and ISO 13485, ensuring compliance with stringent quality standards for medical devices. The company also engages in collaborations with scientific and industrial partners on international projects, which supports its product development and validation efforts.
Keywords: Immunoassays, diagnostics, analytical reagents, food safety, infectious serology, quality assurance, ISO 13485, proficiency testing, test kits, medical laboratories